Tilebio Ltd.
Analysis completed on 3/11/2026
Tilebio Ltd. proposes a highly innovative and useful AI technology for cancer diagnostics, anchored in reputable research institutions. However, the submission's claims regarding traction and audience reach ('most people have used my product', 'everyone') are extremely exaggerated and unsupported for a 2024 startup with a 6-person team. As a result, despite high marks for technical innovation and potential real-world utility, the lack of verifiable traction and poor response quality on metric fields severely limits the overall score.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline